600276 恒瑞医药
2023/09 - 九个月
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额4,308,8711,265,2654,218,8163,431,9353,816,833
投资活动产生之现金流量净额1,237,586390,289(546,263)1,797,829(1,945,440)
筹资活动产生之现金流量净额(3,089,943)(318,770)(998,322)291,188(718,508)
汇率变动对现金及现金等价物的影响19,69680,497(16,866)(89,079)12,307
现金及现金等价物净增加/(减少)2,476,2101,417,2812,657,3655,431,8731,165,191
期初现金及现金等价物余额14,537,43713,120,15610,462,7915,030,9183,865,727
期末现金及现金等价物余额17,013,64814,537,43713,120,15610,462,7915,030,918